Ravulizumab Outcomes in Polish Patients With aHUS

Clinical trial NCT07399730 · RECRUITING

Trial details

NCT number: NCT07399730
Sponsor: AstraZeneca
Status: RECRUITING
Study type: OBSERVATIONAL

Atypical Hemolytic Uremic Syndrome

Start date: 2026-06-24
Primary completion: 2029-09-30
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.